[Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma].

Systemic therapy in uro-oncology is currently undergoing major changes. In the past, drug therapies only showed good treatment results in metastasized testicular tumors. New developments indicate that an improved understanding of tumor biology will lead to targeted treatment strategies for metastatic prostate, urothelial and renal cell carcinoma. In the following article, we summarize the practice-relevant innovations in systemic therapy in the guidelines on prostate cancer, transitional cell carcinoma of the bladder and renal cell carcinoma.

Der Urologe. Ausg. A. 2020 Apr 16 [Epub ahead of print]

A Eisenhardt, C-H Ohlmann, C Doehn

Praxiskliniken Urologie Rhein Ruhr, Schulstr. 11, 45468, Mülheim an der Ruhr, Deutschland. ., Klinik für Urologie, Malteser Krankenhaus Seliger Gerhard Bonn, Bonn, Deutschland., Urologikum Lübeck, Lübeck, Deutschland.

email news signup